
COAGADEX® (Coagulation Factor X, Human) | Factor X Deficiency …
COAGADEX is the first and only treatment specifically for hereditary factor X deficiency. COAGADEX can be taken in different ways—routinely to help prevent bleeding, with surgery to help prevent bleeding, or as needed (on-demand) if bleeding starts.
Coagadex® Coagulation Factor X (Human) for Healthcare …
COAGADEX Is the First and Only Treatment Specifically for Hereditary Factor X Deficiency. COAGADEX is high purity—94% factor X 1; Single-factor plasma-derived factor X concentrate is the only treatment recommended by the National Hemophilia Foundation's Medical and Scientific Advisory Council (MASAC) for hereditary factor X deficiency.
Dosing and Administration | COAGADEX® (Coagulation Factor X, …
Indications and Usage for COAGADEX. COAGADEX, a plasma-derived blood coagulation factor X concentrate, is indicated in adults and children with hereditary factor X deficiency for: Routine prophylaxis to reduce the frequency of bleeding episodes; On-demand treatment and control of bleeding episodes
Coagadex - European Medicines Agency (EMA)
Coagadex is a medicine used for the treatment and prevention of bleeding (including during and after an operation) in patients with hereditary factor X deficiency. Factor X deficiency is a bleeding disorder caused by lack of factor X, a protein needed for normal clotting of the blood.
COAGADEX | FDA - U.S. Food and Drug Administration
2023年4月19日 · Tradename: COAGADEX Manufacturer: Bio Products Laboratory Limited Indication: Indicated in adults and children with hereditary Factor X deficiency for:
欧盟批准 Coagadex 用于治疗遗传性 X 因子缺陷 - 丁香园
2016年4月5日 · Coagadex 旨在遗传性因子 X 缺陷患者中用于出血发作的治疗与预防,以及用于围手术期处理。 在欧洲,Coagadex 是首个也是唯一一个被许可专门用于这种罕见出血性疾病的治疗药物。
COAGADEX- coagulation factor x human kit - DailyMed
2024年10月29日 · COAGADEX is a medicine given as an infusion into the vein to replace the clotting factor that is missing in people with Factor X deficiency. Factor X deficiency is an inherited bleeding disorder that prevents blood from clotting normally. COAGADEX is used to treat, control or reduce bleeding in patients with hereditary Factor X deficiency.
FDA 批准 X 因子药物 Coagadex 用于罕见遗传性出血疾病
2015年10月23日 · Coagadex 来源于人类血浆,这款药物适用于患有遗传性因子 X 缺陷的 12 岁及以上年龄患者,用于按需治疗及出血发作控制,及在患有轻微遗传性因子 X 缺陷的患者中用于围手术期(从住院到术后出院的时间)出血管理。
COAGADEX, Coagulation Factor X (Human), is a plasma-derived human blood coagulation factor indicated in adults and children with hereditary Factor X deficiency for: Routine prophylaxis to reduce the frequency of bleeding episodes (1)
Coagadex is a medicine used for the treatment and prevention of bleeding (including during and after an operation) in patients with hereditary factor X deficiency. Factor X deficiency is a bleeding disorder caused by lack of factor X, a protein needed for normal clotting of the blood.
- 某些结果已被删除